Quantcast

Latest multiple sclerosis Stories

2014-07-24 08:34:45

Net Sales $279 Million; Increase of 42% over Prior Year Non-GAAP Results ANAHEIM, Calif., July 24, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter ended June 30, 2014. Three Months Ended Three Months Ended 06/30/14 06/30/13 Percentage Change --------------------- --------------------- ----------------- GAAP Net Sales...

2014-07-22 12:27:43

Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass., July 22, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of audited multiple sclerosis (MS) patients currently treated with Biogen Idec's oral disease-modify therapy (DMT) Tecfidera have ever experienced flushing and/or gastrointestinal events while on the therapy. However, few...

2014-07-17 08:28:21

- Largest Global Scientific, Research and Medical Gathering of Professionals Advancing Research and Treatment in Multiple Sclerosis - BOSTON, July 17, 2014 /PRNewswire/ -- The upcoming 2014 Joint ACTRIMS-ECTRIMS Meeting will be held on September 10-13 at the John B. Hynes Veteran Memorial Convention Center in Boston, Massachusetts (USA). This meeting, MSBoston2014, will host the largest single gathering of scientists, researchers, medical doctors and health care professionals focused on...

2014-07-13 23:03:05

Every Month Hands-On Physical Therapy Raises Money for an Important Cause: This Month Was the Fight Against Multiple Sclerosis Astoria, New York (PRWEB) July 13, 2014 Multiple Sclerosis (MS) is an autoimmune disease that affects the central nervous system. With an autoimmune disease the immune system attacks the person’s body instead of the threats and diseases it was designed to fight. In the case of MS, the immune system eats away at the sheath that protects the nerves. Ultimately...

2014-06-29 23:00:34

DailyGossip.org publishes a useful review to the Natural Multiple Sclerosis Cure program to help patients find a way to feel better and eliminate symptoms Denver, Colorado (PRWEB) June 29, 2014 In its newly published review, Daily Gossip Magazine reveals that multiple sclerosis actually is commonly described as one of the most debilitating and discouraging conditions that patients can be diagnosed with. The author of the Natural Multiple Sclerosis Cure claims to know that perfectly well,...

2014-06-26 23:02:12

Dr. Arash Bereliani, the founder of the IV Therapy Center in Beverly Hills, spoke recently about a new study showing that intravenous vitamin C is useful for patients with Epstein-Barr virus antibodies. Beverly Hills, CA (PRWEB) June 26, 2014 A new study published in the journal Medical Science Monitor has found that patients who have high levels of Epstein-Barr virus (EBV) antibodies can benefit from intravenous vitamin C. The researchers, Nina A. Mikirova and Ronald Hunninghake of...

2014-06-26 12:29:42

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Multiple Sclerosis -- KOL Insight and Consensus Outlook Moduleshttp://www.reportbuyer.com/pharma_healthcare/diseases/multiple_sclerosis_kol_insight_consensus_outlook_modules.html IntroductionThe multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen's Tecfidera has revolutionised multiple sclerosis treatment in the U.S., eroding significant market...

2014-06-25 12:30:05

MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C. PharmaCare. TECFIDERA(TM) is a first-line oral treatment for adults with relapsing-remitting multiple sclerosis (RRMS). TECFIDERA(TM) is indicated as monotherapy for the treatment of RRMS to reduce the frequency of clinical exacerbations and to delay the progression of disability.(1) "TECFIDERA is...

2014-06-17 16:26:18

The Conrad N. Hilton Foundation is issuing an open invitation for research into Multiple Sclerosis, the leading cause of neurological disability in young adults. LOS ANGELES, June 17, 2014 /PRNewswire-USNewswire/ -- The Conrad N. Hilton Foundation is issuing an open invitation to submit proposals for the Marilyn Hilton Award for Innovation in Multiple Sclerosis Research. The goal of the award is to stimulate innovative and potentially paradigm-shifting research on Progressive...

2014-06-12 12:30:07

Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass., June 12, 2014 /PRNewswire/ -- Decision Resources Group finds that, within one year of commercial availability, 100 percent of surveyed U.S. neurologists have prescribed Biogen Idec's Tecfidera to at least one of their multiple sclerosis (MS) patients, far surpassing the one-year trial rate for...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related